112 related articles for article (PubMed ID: 14705983)
1. Cloning of a human antibody directed against human neuroblastoma cells and specific for human translation elongation factor 1alpha.
Schilbach K; Kreyenberg H; Geiselhart A; Niethammer D; Handgretinger R
Tissue Antigens; 2004 Feb; 63(2):122-31. PubMed ID: 14705983
[TBL] [Abstract][Full Text] [Related]
2. Distribution of natural antibody against human neuroblastoma among children with or without neuroblastoma.
Fukuda M; Nozaki C; Ishiguro Y; Horibe K
Med Pediatr Oncol; 2001 Jan; 36(1):147-8. PubMed ID: 11464870
[TBL] [Abstract][Full Text] [Related]
3. Normal human serum contains a natural IgM antibody cytotoxic for human neuroblastoma cells.
Ollert MW; David K; Schmitt C; Hauenschild A; Bredehorst R; Erttmann R; Vogel CW
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4498-503. PubMed ID: 8633097
[TBL] [Abstract][Full Text] [Related]
4. Initial characterization of the apoptosis-inducing receptor for natural human anti-neuroblastoma IgM.
David K; Heiligtag S; Ollert MW; Teppke M; Vogel CW; Bredehorst R
Med Pediatr Oncol; 2001 Jan; 36(1):251-7. PubMed ID: 11464898
[TBL] [Abstract][Full Text] [Related]
5. The cytolysis of human neuroblastoma cells by a natural IgM 'antibody'-complement system in pregnancy serum.
Bolande RP; Mayer DC
Cancer Invest; 1990; 8(6):603-11. PubMed ID: 2292053
[TBL] [Abstract][Full Text] [Related]
6. Complement-dependent lysis of tumor cells by a baboon IgM antibody to a tumor-associated antigen.
Hunt KK; Shibata M; Gupta RK; Morton DL
Cancer Immunol Immunother; 1992; 34(6):377-82. PubMed ID: 1563014
[TBL] [Abstract][Full Text] [Related]
7. A novel metastatic animal model reflecting the clinical appearance of human neuroblastoma: growth arrest of orthotopic tumors by natural, cytotoxic human immunoglobulin M antibodies.
Engler S; Thiel C; Förster K; David K; Bredehorst R; Juhl H
Cancer Res; 2001 Apr; 61(7):2968-73. PubMed ID: 11306475
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic activity against human neuroblastoma and melanoma cells mediated by IgM antibodies derived from peripheral blood of healthy donors.
Devarapu SK; Mamidi S; Plöger F; Dill O; Blixt O; Kirschfink M; Schwartz-Albiez R
Int J Cancer; 2016 Jun; 138(12):2963-73. PubMed ID: 26830059
[TBL] [Abstract][Full Text] [Related]
9. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
[TBL] [Abstract][Full Text] [Related]
10. Tumour cell binding by a human monoclonal IgM antibody from the spleen of a non-tumour-associated patient is due to somatic mutations in the VH gene.
Bohn J; Niemann B; Roggenbuck D; Döcke W; Jahn S
Clin Exp Immunol; 1995 Mar; 99(3):376-83. PubMed ID: 7882560
[TBL] [Abstract][Full Text] [Related]
11. Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells.
Juhl H; Petrella EC; Cheung NK; Bredehorst R; Vogel CW
Immunobiology; 1997 Nov; 197(5):444-59. PubMed ID: 9413745
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-2 enhancement of monoclonal antibody-mediated cellular cytotoxicity against human melanoma.
Munn DH; Cheung NK
Cancer Res; 1987 Dec; 47(24 Pt 1):6600-5. PubMed ID: 3499978
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of in vivo anti-neuroblastoma activity of human natural IgM.
Ollert MW; David K; Vollmert C; Juhl H; Erttmann R; Bredehorst R; Vogel CW
Eur J Cancer; 1997 Oct; 33(12):1942-8. PubMed ID: 9516829
[TBL] [Abstract][Full Text] [Related]
14. IgM monoclonal antibody JD118 recognizes an inducible antigen target for human-complement-mediated cytotoxicity against neoplastic B cells.
Czuczman MS; Garin-Chesa P; Lemoli RM; Scheinberg DA
Cancer Immunol Immunother; 1993 Jun; 36(6):387-96. PubMed ID: 8500111
[TBL] [Abstract][Full Text] [Related]
15. Lysis of P3HR-1 cells induced to enter the viral cycle by antibody-dependent and independent immunological mechanisms.
Kurakata S; Ramos OF; Klein G; Klein E
Cell Immunol; 1989 Oct; 123(1):134-47. PubMed ID: 2550147
[TBL] [Abstract][Full Text] [Related]
16. Differential binding avidities of human IgM for staphylococcal protein A derive from specific germ-line VH3 gene usage.
Hakoda M; Kamatani N; Hayashimoto-Kurumada S; Silverman GJ; Yamanaka H; Terai C; Kashiwazaki S
J Immunol; 1996 Oct; 157(7):2976-81. PubMed ID: 8816405
[TBL] [Abstract][Full Text] [Related]
17. Chimerization of LL2, a rapidly internalizing antibody specific for B cell lymphoma.
Leung SO; Shevitz J; Pellegrini MC; Dion AS; Shih LB; Goldenberg DM; Hansen HJ
Hybridoma; 1994 Dec; 13(6):469-76. PubMed ID: 7737671
[TBL] [Abstract][Full Text] [Related]
18. Nucleotide sequence analysis of a human monoclonal antibody TONO-1 with cytotoxic potential for T-leukemia/lymphoma cells.
Numasaki M; Nakamura K; Fukuoka Y; Saeki H; Hanai N; Kudo T
Immunol Lett; 2001 Jan; 75(3):167-77. PubMed ID: 11166372
[TBL] [Abstract][Full Text] [Related]
19. Anti-GM(2) IgM antibody-induced complement-mediated cytotoxicity in patients with dysimmune neuropathies.
Cavanna B; Jiang H; Allaria S; Carpo M; Scarlato G; Nobile-Orazio E
J Neuroimmunol; 2001 Mar; 114(1-2):226-31. PubMed ID: 11240036
[TBL] [Abstract][Full Text] [Related]
20. Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigen.
David K; Ollert MW; Vollmert C; Heiligtag S; Eickhoff B; Erttmann R; Bredehorst R; Vogel CW
Cancer Res; 1999 Aug; 59(15):3768-75. PubMed ID: 10446994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
